Enterocolitis: Clinical Trials

44 trials for Enterocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 8 unknown, 3 recruiting, 3 terminated. 44 Phase 2, 9 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 244Completed 26, Unknown 8, Recruiting 3, Terminated 3, Active not recruiting 2, Withdrawn 2
Phase 19Completed 4, Terminated 2, Unknown 2, Recruiting 1
Phase 33Active not recruiting 1, Completed 1, Unknown 1

Follow Enterocolitis: new trials by email Literature Review of Enterocolitis trials Research Report on Enterocolitis

Trials (filtered) newest first · largest first

All 44 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)
ST266 - Necrotizing Enterocolitis
Phase 1 / Phase 2RecruitingNoveome Biotherapeutics, formerly Stemnion362024-08-192026-04-13
RIC-NEC Randomized Controlled Trial
Remote ischemic conditioning (RIC) + Standard of Care for NEC, Standard of Care for NEC - Necrotizing Enterocolitis
Phase 2CompletedThe Hospital for Sick Children862023-02-092026-11-03
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Alanyl-glutamine - Clostridioides Difficile Infection, Clostridium Difficile Infection
Phase 2RecruitingUniversity of Virginia2602021-06-012024-10-26
Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis
Melatonin 6 MG, Breast Milk - Necrotizing Enterocolitis
Phase 1 / Phase 2CompletedIlocos Training and Regional Medical Center1002021-03-012024-06-20
Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
MAS825, Placebo - NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations
Phase 2Active not recruitingNovartis Pharmaceuticals172020-12-182026-10-09
The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants
Lactobacillus Reuteri DSM 17938, Placebo - Necrotizing Enterocolitis, Sepsis
Phase 2UnknownChildren's Hospital and Institute of Child Health, Multan1202020-10-012020-09-09
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
Lyophilized fecal microbiota transplant, Lyophilized sterile fecal filtrate - Clostridia Difficile Colitis, Clostridium Difficile Diarrhea
Phase 2CompletedUniversity of Alberta1382019-03-212024-06-04
Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO
Inhaled Nitric Oxide, Placebo - Anemia
Phase 1 / Phase 2UnknownNew York Medical College502019-02-062019-04-24
Human Milk Fortification in Extremely Preterm Infants
H2MF, Bovine milk-based fortifier - Necrotizing Enterocolitis, Sepsis
Phase 2 / Phase 3Active not recruitingThomas Abrahamsson, MD, PhD2292019-02-012024-07-23
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
Vancomycin, Placebo - Recurrent Clostridium Difficile Infection, Clostridium Difficile Infection
Phase 2CompletedUniversity of Wisconsin, Madison792018-05-212025-05-25
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
LFMT, LSFF - Enterocolitis, Recurrent Clostridium Difficile Infection
Phase 2CompletedDina Kao112018-02-142020-02-20
Antibiotic "Dysbiosis" in Preterm Infants
Antibiotic, Gastric fluid, Breast milk - Enterocolitis, Necrotizing, Bacteremia
Phase 2CompletedUniversity of Florida982017-01-162024-06-05
Heat Killed Probiotics in the Prevention of Necrotizing Enterocolitis
Heat Inactivated probiotics, Placebo - Necrotizing Enterocolitis, Enterocolitis, Necrotizing
Phase 2UnknownShaare Zedek Medical Center4502016-06-012016-06-16
IBP-9414 for the Prevention of Necrotizing Enterocolitis
IBP-9414, Placebo - Necrotizing Enterocolitis
Phase 2CompletedInfant Bacterial Therapeutics1202016-05-272017-12-29
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
SMOFlipid - Cholestasis, Jaundice, Obstructive
Phase 1 / Phase 2TerminatedUniversity of Florida22016-05-012017-04-17
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
fecal microbiota - Clostridium Difficile Colitis
Phase 2RecruitingDuke University772016-04-012026-08-27
Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection
Single-infusion FMT, Vancomycin (before randomization), multiple-infusion FMT - Clostridium Difficile, Pseudomembranous Colitis
Phase 2CompletedCatholic University of the Sacred Heart582016-03-012018-02-09
Prediction of NEC With Urinary iFABP
Assessment of urinary iFABP, Administration of enteral feedings - Prematurity, Necrotizing Enterocolitis
Phase 2WithdrawnLoma Linda University2014-11-012015-05-14
Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile
Cultured human intestinal microbiota, Vancomycin, Metronidazole - Clostridium Difficile
Phase 2CompletedPer Hellström602014-10-012019-01-09
Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
Peripheral blood stem cell mobilisation and collection, High-dose chemotherapy, Bone marrow derived allogeneic MMSCs infusion - Neutropenic Enterocolitis, Myeloablative Chemotherapy Induced Bone Marrow Aplasia
Phase 1 / Phase 2UnknownBurnasyan Federal Medical Biophysical Center162014-05-012015-06-10

Showing 20 of 44. Sign in to see all of them.

Narrower conditions

Enterocolitis, Necrotizing (28)  ·  Enterocolitis, Pseudomembranous (12)  ·  Premature Birth (9)  ·  Clostridium Infections (6)  ·  Sepsis (6)  ·  Bronchopulmonary Dysplasia (2)  ·  Diarrhea (2)  ·  Ductus Arteriosus, Patent (2)  ·  Dysentery (2)  ·  Intestinal Diseases (2)  ·  Intestinal Perforation (2)  ·  Short Bowel Syndrome (2)  ·  Anemia (1)  ·  Anemia, Aplastic (1)

Broader conditions

Digestive System Diseases (43)  ·  Gastroenteritis (43)  ·  Gastrointestinal Diseases (43)  ·  Intestinal Diseases (42)  ·  Infections (22)  ·  Bacterial Infections and Mycoses (14)  ·  Bacterial Infections (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Gram-Positive Bacterial Infections (12)  ·  Pathologic Processes (11)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Obstetric Labor Complications (9)  ·  Obstetric Labor, Premature (9)  ·  Pregnancy Complications (9)

Interventions

Vancomycin (4)  ·  Fecal Microbiota Transplantation (2)  ·  Glutamine (2)  ·  Milk, Human (2)  ·  Saline Solution (2)  ·  4'-galactooligosaccharide (1)  ·  Adjuvants, Pharmaceutic (1)  ·  Ampicillin (1)  ·  Anti-Bacterial Agents (1)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Arginine (1)  ·  Biological Evolution (1)  ·  Cefotaxime (1)  ·  Docosahexaenoic Acids (1)  ·  Drainage (1)

Sponsors

Shaare Zedek Medical Center (3)  ·  Ain Shams University (2)  ·  Coordinación de Investigación en Salud, Mexico (2)  ·  Genzyme, a Sanofi Company (2)  ·  Novartis Pharmaceuticals (2)  ·  University of California, San Francisco (2)  ·  University of Florida (2)  ·  Alberta Children's Hospital (1)  ·  Bnai Zion Medical Center (1)  ·  Burnasyan Federal Medical Biophysical Center (1)  ·  Catholic University of the Sacred Heart (1)  ·  Children's Hospital and Institute of Child Health, Multan (1)  ·  China Medical University Hospital (1)  ·  Dina Kao (1)  ·  Duke University (1)

Countries

United States (21)  ·  Canada (8)  ·  Israel (4)  ·  Sweden (4)  ·  United Kingdom (3)  ·  Mexico (2)  ·  China (1)  ·  Czechia (1)  ·  Egypt (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  Philippines (1)  ·  Puerto Rico (1)  ·  Russia (1)

Top investigators

Cathy Hammerman, MD (3)  ·  Josef Neu, MD (3)  ·  Dina Kao, MD (2)  ·  Agostino Pierro, OBE, MD (1)  ·  Arieh Riskin, MD (1)  ·  Changlian Zhu, PhD (1)  ·  Daisy Evangeline C Garcia, MD (1)  ·  Daniel H Teitelbaum, MD (1)  ·  Danny Benjamin, MD, PhD, MPH (1)  ·  David Sigalet, MD PhD (1)  ·  Edmund LaGamma, MD (1)  ·  GHada A. Saleh, MRCPCH (1)  ·  Gaelle Sadani, MD (1)  ·  Gary M Cox, MD (1)

Results publications

PMID 10440607, PMID 11171619, PMID 17636753, PMID 18829790, PMID 20980771, PMID 21871249, PMID 22818551, PMID 22955430, PMID 23323867, PMID 23331802, PMID 23453547, PMID 25104129, PMID 25155966, PMID 25534724, PMID 25534727, PMID 25861285, PMID 25927273, PMID 26340878, PMID 27013431, PMID 29851107, PMID 29906796, PMID 30340932, PMID 30850756, PMID 31255386, PMID 31537446, PMID 32771013, PMID 33006765, PMID 33076939, PMID 33479274, PMID 33671220, PMID 33763652, PMID 33923278, PMID 34815288, PMID 37308133, PMID 37474181, PMID 38545091, PMID 39373498, PMID 40601321, PMID 40997843, PMID 9712236

NIH funding

K08HD052885 (1), R21HD088005 (1)